The Yale Multiple Sclerosis Symposium, taking place on May 8, 2026, at the New Haven Lawn Club in New Haven, Connecticut, will provide clinicians with an in-depth update on the rapidly evolving field of Multiple Sclerosis (MS). MS remains one of the most common neurological disorders causing disability in young adults, with more than one million individuals currently affected in the United States.Advances in disease phenotyping, diagnostic imaging, and therapeutic strategies continue to reshape ...

Despite therapeutic advances, the prognosis of pulmonary hypertension remains poor which likely reflects in part delayed detection of the disease and scarcity of disease modifying therapies currently available. The former is important especially amongst health care providers given the myriad of conditions that can result in pulmonary hypertension, including chronic liver disease, left heart disease, and connective tissue disease. Early recognition of the pulmonary hypertension and recognizing th...

This will be a current and authoritative one day course on systemic lupus erythematosus, with comprehensive sessions on pathogenesis, diagnosis and treatment. Our distinguished faculty will interact with participants through didactic lectures and interactive panel discussions.

This meeting will recap the major takeaways from ASH through a program designed for hematologists involved in the treatment of patients with blood cancer.